Novacyt S.A. AGM Voting
13 Juni 2022 - 08:00AM
RNS Non-Regulatory
TIDMNCYT
Novacyt S.A.
13 June 2022
Novacyt S.A.
("Novacyt", the "Company" or the "Group")
AGM voting
Paris, France and Camberley, UK - 13 June 2022 - Novacyt
(EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in
clinical diagnostics, will be holding its annual general meeting
(AGM) as an open online meeting at 2pm CEST/1pm BST on 21 June
2022. As usual, and in accordance with French corporate law, the
AGM comprises both ordinary and extraordinary general meetings.
Under French law, for the meetings to be quorate at the first
attempt, at least 20% of the shareholders must vote on the ordinary
resolutions and 25% of the shareholders must vote on the
extraordinary resolutions. Shareholders are therefore strongly
encouraged to submit their proxy votes either by post, email or
vote electronically in accordance with the instructions in the
notice convening the meeting, copies of which are available in the
General Meetings section on the Company's website at
www.novacyt.com/investors .
Following registration and proof of shareholding, shareholders
will be able to virtually attend the AGM and vote online during the
meeting if they wish. Following the meeting, a recording of the AGM
will be available on the Company's website at
www.novacyt.com/investors . Shareholders who have already voted
(through a proxy, using the AGM or Votaccess portals) will be
allowed to attend the AGM but will not be able to vote twice.
- End -
Contacts
Novacyt SA
David Allmond, Chief Executive Officer
James McCarthy, Chief Financial Officer
+44 (0)1276 600081
SP Angel Corporate Finance LLP (Nominated Adviser and
Broker)
Matthew Johnson / Charlie Bouverat (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
+44 (0)20 3470 0470
Numis Securities Limited (Joint Broker)
Freddie Barnfield / James Black / Duncan Monteith
+44 (0)20 7260 1000
Allegra Finance (French Listing Sponsor)
Rémi Durgetto / Yannick Petit
+33 (1) 42 22 10 10
r.durgetto@allegrafinance.com ; y.petit@allegrafinance.com
FTI Consulting (International)
Victoria Foster Mitchell / Alex Shaw
+44 (0)20 3727 1000
victoria.fostermitchell@fticonsulting.com /
Alex.Shaw@fticonsulting.com
FTI Consulting (France)
Arnaud de Cheffontaines
+33 (0)147 03 69 48
arnaud.decheffontaines@fticonsulting.com
About Novacyt Group
The Novacyt Group is an international diagnostics business
generating an increasing portfolio of in vitro and molecular
diagnostic tests. Its core strengths lie in diagnostics product
development, commercialisation, contract design and manufacturing.
The Company supplies an extensive range of high-quality assays and
reagents worldwide. The Group directly serves microbiology,
haematology and serology markets as do its global partners, which
include major corporates.
For more information, please refer to the website:
www.novacyt.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABKBBBDBKBKAD
(END) Dow Jones Newswires
June 13, 2022 02:00 ET (06:00 GMT)
Novacyt (EU:ALNOV)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Novacyt (EU:ALNOV)
Historical Stock Chart
Von Mär 2023 bis Mär 2024